AR045005A1 - Composiciones farmaceuticas que comprenden 11-piperazin-1-ildibenzo[b,f][1,4]tiazepin-7-ol - Google Patents

Composiciones farmaceuticas que comprenden 11-piperazin-1-ildibenzo[b,f][1,4]tiazepin-7-ol

Info

Publication number
AR045005A1
AR045005A1 ARP040102346A ARP040102346A AR045005A1 AR 045005 A1 AR045005 A1 AR 045005A1 AR P040102346 A ARP040102346 A AR P040102346A AR P040102346 A ARP040102346 A AR P040102346A AR 045005 A1 AR045005 A1 AR 045005A1
Authority
AR
Argentina
Prior art keywords
disorders
pharmaceutically acceptable
bipolar
symptoms
tiazepin
Prior art date
Application number
ARP040102346A
Other languages
English (en)
Original Assignee
Schuckmann Alfred Von
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schuckmann Alfred Von filed Critical Schuckmann Alfred Von
Publication of AR045005A1 publication Critical patent/AR045005A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Un método para el tratamiento de ansiedad, agitación, hostilidad, pánico, desórdenes de la alimentación, síntomas afectivos, síntomas emocionales, síntomas psicóticos positivos y negativas asociados comúnmente con esquizofrenia, demencia, ansiedad, depresión, trastornos emocionales, trastornos bipolares, manía bipolar, depresión bipolar, trastornos cognitivos y trastornos neurodegenerativos, que comprende administrar una cantidad eficaz de un compuesto de fórmula (1), o su sal farmacéuticamente aceptable. Composición farmacéutica que comprende una cantidad eficaz de un compuesto de fórmula (1) o su sal farmacéuticamente aceptable y por lo menos un diluyente o portador farmacéuticamente aceptable.
ARP040102346A 2003-07-02 2004-07-02 Composiciones farmaceuticas que comprenden 11-piperazin-1-ildibenzo[b,f][1,4]tiazepin-7-ol AR045005A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48444203P 2003-07-02 2003-07-02

Publications (1)

Publication Number Publication Date
AR045005A1 true AR045005A1 (es) 2005-10-12

Family

ID=33563990

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040102346A AR045005A1 (es) 2003-07-02 2004-07-02 Composiciones farmaceuticas que comprenden 11-piperazin-1-ildibenzo[b,f][1,4]tiazepin-7-ol

Country Status (5)

Country Link
US (1) US20050026899A1 (es)
AR (1) AR045005A1 (es)
TW (1) TW200507854A (es)
UY (1) UY28401A1 (es)
WO (1) WO2005002587A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8715699B2 (en) 2009-12-31 2014-05-06 Kempharm, Inc. Amino acid conjugates of quetiapine, process for making and using the same
WO2011112657A1 (en) 2010-03-11 2011-09-15 Kempharm, Inc. Fatty acid conjugates of quetiapine, process for making and using the same

Also Published As

Publication number Publication date
UY28401A1 (es) 2005-01-31
US20050026899A1 (en) 2005-02-03
TW200507854A (en) 2005-03-01
WO2005002587A1 (en) 2005-01-13

Similar Documents

Publication Publication Date Title
AR045004A1 (es) Composiciones farmaceuticas que comprenden 11-piperazin-1-ildibenzo[b,f][1,4]tiazepina
GT200100183A (es) Derivados de quinolina y quinazolina.
PE20070541A1 (es) Compuestos y composiciones que comprenden isoindol-imidas
PT1404324E (pt) Formas de dosagem administradas oralmente de pró-fármacos análogas de gaba tendo toxicidade reduzida
BR0207961A (pt) Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas
BRPI0609785B8 (pt) benzotiofenos substituídos por piperazina, composição farmacêutica, processo para produzir uma composição farmacêutica, uso de benzotiofenos substituídos por piperazina ou um sal do mesmo, e, processo para produzir benzotiofenos substituídos por piperazina
DE60239931D1 (de) Kombinationstherapie
DE602004032522D1 (de) Mit n-alkylhydroxamsäuren substituierte isoindolylverbindungen und deren pharmazeutische verwendung
ES2096262T3 (es) Nuevas cyclosporins modificadas en la posicion 1.
BR0210122A (pt) Composto ou um sal farmaceuticamente aceitável do mesmo, método para o tratamento ou prevenção de uma doença, uso do composto ou de seu sal, e, método para preparar o mesmo
BRPI0416752A (pt) composição farmacêutica, uso de um ou mais compostos, método para a prevenção ou tratamento de distúrbios, compostos, e, processo para a preparação de uma composição farmacêutica
BR0213355A (pt) composições farmacêuticas
BR0314299A (pt) Derivados de pirrolidona como inibidores de mao-b
BRPI0416534A (pt) composições multiparticuladas com estabilidade melhorada
GT199900154A (es) Agentes farmaceuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas.
BRPI0411936A (pt) composto, processo para a sua preparação, composição farmacêutica que comprende o mesmo, utilização de um composto, métodos para o tratamento e profilaxia de distúrbios do sistema nervoso central, alimentares e obesidade
BRPI0411176A (pt) combinação farmacêutica consistindo de modafinil e outra droga
UY27018A1 (es) Derivados de la pirimidina
AR046874A1 (es) Nuevos metodos
BR0314713A (pt) Processos e reagentes para o tratamento de doenças e distúrbios associados com nìveis aumentados de citocinas pró-inflamatórias
BRPI0410623A (pt) composto, processo para preparação de um composto, composição farmacêutica, e, utilização de um composto
GT200400068A (es) Derivados de 3-azabiciclo[3.2.1]octano
AR045005A1 (es) Composiciones farmaceuticas que comprenden 11-piperazin-1-ildibenzo[b,f][1,4]tiazepin-7-ol
ES2192608T3 (es) Uso de derivados de alilamina tales como terbinafina, en la fabricacion de un medicamento para el tratamiento de la infeccion por helicobacter pylori de enfermedades asociadas.
BR0212077A (pt) Compostos de aminopirróis como agentes antiinflamatórios

Legal Events

Date Code Title Description
FA Abandonment or withdrawal